领航医药生物科技拟扩充业务至区块链技术

格隆汇2025-04-25

格隆汇4月25日丨领航医药生物科技(00399.HK)公告，公司拟扩充业务至区块链技术，进军数码创新行业。集团将启动研究开发项目，集中于区块链的相关基础设施及共通关键技术，目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端，并开发新业务模型及收益来源。集团将成立专门技术团队，凭藉与领先区块链平台及学术机构的合作伙伴关系，带头进行研究及开发。此计划符合全球...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530135670?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-25 21:07","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2530135670","market":"hk","top_or_hot":-1,"title":"领航医药生物科技拟扩充业务至区块链技术","media":"格隆汇","content":"<div>\n<p>格隆汇4月25日丨领航医药生物科技(00399.HK)公告，公司拟扩充业务至区块链技术，进军数码创新行业。集团将启动研究开发项目，集中于区块链的相关基础设施及共通关键技术，目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端，并开发新业务模型及收益来源。集团将成立专门技术团队，凭藉与领先区块链平台及学术机构的合作伙伴关系，带头进行研究及开发。此计划符合全球...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>领航医药生物科技拟扩充业务至区块链技术</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n领航医药生物科技拟扩充业务至区块链技术\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-25 21:07 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇4月25日丨领航医药生物科技(00399.HK)公告，公司拟扩充业务至区块链技术，进军数码创新行业。集团将启动研究开发项目，集中于区块链的相关基础设施及共通关键技术，目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端，并开发新业务模型及收益来源。集团将成立专门技术团队，凭藉与领先区块链平台及学术机构的合作伙伴关系，带头进行研究及开发。此计划符合全球...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1124","symbol_name":"贸易公司与经销商","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b","article_id":"2530135670","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504252111419745120d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2530135670","pubTimestamp":1745586421,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇4月25日丨领航医药生物科技公告，公司拟扩充业务至区块链技术，进军数码创新行业。集团将启动研究开发项目，集中于区块链的相关基础设施及共通关键技术，目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端，并开发新业务模型及收益来源。集团将成立专门技术团队，凭藉与领先区块链平台及学术机构的合作伙伴关系，带头进行研究及开发。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1124":"贸易公司与经销商","00399":"星太链集团"},"translate_title":"Linghang Pharmaceutical Biotechnology plans to expand its business to blockchain technology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"格隆汇4月25日丨领航医药生物科技(00399.HK)公告，公司拟扩充业务至区块链技术，进军数码创新行业。集团将启动研究开发项目，集中于区块链的相关基础设施及共通关键技术，目标为提升多类数码及商业交易的透明度、安全性及效率。此计划乃为将集团定位在创新技术应用的前端，并开发新业务模型及收益来源。集团将成立专门技术团队，凭藉与领先区块链平台及学术机构的合作伙伴关系，带头进行研究及开发。此计划符合全球数码转型趋势，并提供机会令集团的收益来源更多元化，同时提升在新兴行业的竞争地位。为支持该计划，公司可能透过不同方式筹集资金，包括配售，以及向股东或财务机构借贷。公司亦可能扩大董事会及高级管理层团队以纳入合资格人士以确保新项目的成功。尽管近年的环境充满挑战，董事对公司的前景仍抱持乐观态度。公司正积极发掘新商机，令收益来源多元化，并实施策略计划以提升表现。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530135670","isCrawlerRequest":true}